Multiwave Imaging

Multiwave Imaging is a medical technology company founded in 2015 in Switzerland by brothers Tryfon and Panos Antonakakis. The company operates at the intersection of metamaterials, artificial intelligence, and medical imaging, with the mission to make MRI available globally. More than two-thirds of the world lacks access to medical imaging, and Multiwave aims to address this gap through its ultra-low-field portable MRI device, MGNTQ™. The MGNTQ™ scanner weighs just over 200 kg and is designed for maximum mobility and affordability. It is positioned as a next-generation portable MRI solution for both diagnostic and preventive care, capable of being moved to the patient's bedside in intensive care, emergency, or intra-operative settings, as well as used in rural areas, medical deserts, home care, retirement homes, and sporting events. The device is AI-powered and requires no specialized infrastructure, no cooling, and little maintenance. It is described as 5-10 times more affordable than a conventional MRI scanner, with a subscription-based model planned post-regulatory approval. Multiwave Technologies AG is registered in Geneva, Switzerland, and has a wholly-owned R&D subsidiary in France, with a US office in Lowell, Massachusetts. The company has partnered with leading institutions such as Imperial College London, Institut Fresnel (CNRS and Aix-Marseille University), Leiden University Medical Center, Mount Sinai Hospital New York, Johns Hopkins, and Brighton and Sussex Medical School. In 2018, Multiwave was awarded Best Young SME by the European Commission for its innovations in medical imaging. The company produced its first brain image with its portable MRI in 2021 and has since delivered scanners for research to several institutions. Multiwave continues to advance its technology through collaborations and feasibility studies, aiming to disrupt the MRI market by providing accessible, affordable imaging solutions for underserved populations worldwide.

Multiwave Imaging was founded in 2015 as Multiwave Technologies AG in Switzerland by brothers Tryfon Antonakakis (PhD) and Panos Antonakakis. The company was established with the goal of making healthcare more accessible and affordable through innovations in metamaterials, artificial intelligence, and medical imaging. In 2016, Multiwave partnered with Imperial College London to develop metamaterial algorithms. In the same year, the company created a wholly-owned R&D subsidiary in France and partnered with Institut Fresnel, a joint laboratory of the French National Research Agency (CNRS) and Aix-Marseille University, to develop next-generation metamaterials for medical imaging. In 2018, Multiwave partnered with Leiden University Medical Center to apply its metamaterial design software to magnetic resonance imaging. That year, the company was awarded Best Young SME by the European Commission for its innovations in medical imaging. A significant milestone occurred in 2021 when Multiwave's portable MRI produced its first brain image. From 2021 to 2023, Multiwave and the A*midex Foundation co-financed the Multiwave Chair of Medical Imaging for its first three years with a budget of €1.3 million. The A*midex Foundation also purchased one portable MRI scanner. Between 2022 and 2023, portable MRI scanners for research were delivered to Mount Sinai Hospital New York (US), with a scanner transferred to Johns Hopkins (US), and to Brighton and Sussex Medical School (UK). In 2023, Multiwave signed a feasibility study with a leading institution (details not fully specified in the source). The company is registered in the canton of Geneva, Switzerland, with registration number CHE-329.584.718. It maintains a US office at 175 Cabot Street, Lowell, MA, USA. The company continues to develop its MGNTQ™ portable MRI device, aiming to make MRI available globally.

• 2023

  Scanner transferred to Johns Hopkins (US) and delivered to Brighton and Sussex Medical School (UK).

• 2023

  Signs feasibility study with a leading institution.

• 2022

  Portable MRI scanner delivered to Mount Sinai Hospital New York (US).

• 2021

  Portable MRI produces its first brain image.

• 2021

  Multiwave and A*midex Foundation co-finance the Multiwave Chair of Medical Imaging for 2021-2023 with a budget of €1.3 million.

• 2018

  Partnership with Leiden University Medical Center to apply metamaterial design software to MRI.

• 2018

  Awarded Best Young SME by the European Commission for innovations in medical imaging.

• 2016

  Partnership with Imperial College London to develop metamaterial algorithms.

• 2016

  Creation of wholly-owned R&D subsidiary in France and partnership with Institut Fresnel (CNRS and Aix-Marseille University).

• 2015

  Multiwave Technologies AG founded in Switzerland by brothers Tryfon and Panos Antonakakis.

Affordable, mobile, and accessible MRI technology for global healthcare, targeting underserved markets and point-of-care settings.

• MGNTQ™

  Ultra-low-field portable MRI device weighing just over 200 kg, designed for maximum mobility and affordability, AI-powered, for diagnostic and preventive care.

1. 1Multiwave | MRI for everyone, everywheremultiwave.ch
2. 2About Us | Multiwavemultiwave.ch
3. 3Corporate | Multiwavemultiwave.ch
4. 4Multiwave Imaging - Wikidatawikidata.org